Oncology

Tumor Biology Cancer Treatment Immunotherapy Cancer Therapies Therapeutics Diagnostic Techniques Treatment Innovations Drug Mechanism Clinical Trials Hematology

5 ARTICLES

last wk.

Pan‑Mass Challenge Kicks Off From Worcester With 6,500 Riders Targeting $79 Million

Organizers say the move to the College of the Holy Cross is meant to help sustain unrestricted funding for Dana‑Farber as federal research support falls.

10 ARTICLES

3w ago

FDA Opens Early Access to KRAS-Targeting Pancreatic Cancer Pill After Strong Survival Data

3 ARTICLES

3mo ago

Family Launches Fundraiser After Girl, 9, Dies Hours After AML Diagnosis

10 ARTICLES

3mo ago

Mayo Clinic AI Flags Pancreatic Cancer on CT Scans Up to Three Years Early

8 ARTICLES

3mo ago

Ben Sasse Reports 76% Tumor Reduction on Experimental Pancreatic Cancer Drug

4 ARTICLES

4mo ago

Young Cancer Survivors Face Double Risk of New Cancers, Alberta Study Finds

3 ARTICLES

4mo ago

CNIO Board Ratifies Cristina Navarro as Managing Director

8 ARTICLES

4mo ago

Telangana Declares Cancer Notifiable, Launches Statewide Registry

6 ARTICLES

4mo ago

Blood Test Detects Glioblastoma With Over 90% Accuracy as Multi‑Site Trial Begins

22 ARTICLES

5mo ago

Global Study Projects Breast Cancer to Exceed 3.5 Million Cases a Year by 2050, With Deaths Near 1.4 Million

10 ARTICLES

5mo ago

Lancet Oncology: 28% of Global Breast Cancer Burden Linked to Six Modifiable Factors

4 ARTICLES

5mo ago

Microplastics Detected in Prostate Tumors in Small NYU Study

4 ARTICLES

6mo ago

Triple Therapy Eradicates Pancreatic Tumors in Mice in CNIO Study

3 ARTICLES

6mo ago

Lung Cancer Tops Deaths in Rhineland-Palatinate as Vorarlberg Sees Falling Mortality

8 ARTICLES

6mo ago

Preclinical Study Flags NPM1 as Potential Target in Some Bowel and Liver Cancers

3 ARTICLES

7mo ago

Zymeworks and BeOne Say Phase 3 Zanidatamab Regimens Top Two Years’ Survival in First-Line HER2+ GEA

Oncology

Pan‑Mass Challenge Kicks Off From Worcester With 6,500 Riders Targeting $79 Million

Tempus AI Agrees to Buy Personalis for $1.5 Billion

Brush‑Swab Test Detects Oral Cancer in One Hour

CAR‑T Cells Targeting GPNMB Eradicate Glioblastoma in Preclinical Models

State Memorial for Richard Scolyer Set for July 13 at Sydney Opera House

FDA Opens Early Access to KRAS-Targeting Pancreatic Cancer Pill After Strong Survival Data

Family Launches Fundraiser After Girl, 9, Dies Hours After AML Diagnosis

Mayo Clinic AI Flags Pancreatic Cancer on CT Scans Up to Three Years Early

Ben Sasse Reports 76% Tumor Reduction on Experimental Pancreatic Cancer Drug

Young Cancer Survivors Face Double Risk of New Cancers, Alberta Study Finds

Never miss stories about

Oncology

CNIO Board Ratifies Cristina Navarro as Managing Director

Telangana Declares Cancer Notifiable, Launches Statewide Registry

Blood Test Detects Glioblastoma With Over 90% Accuracy as Multi‑Site Trial Begins

Global Study Projects Breast Cancer to Exceed 3.5 Million Cases a Year by 2050, With Deaths Near 1.4 Million

Lancet Oncology: 28% of Global Breast Cancer Burden Linked to Six Modifiable Factors

Microplastics Detected in Prostate Tumors in Small NYU Study

Triple Therapy Eradicates Pancreatic Tumors in Mice in CNIO Study

Lung Cancer Tops Deaths in Rhineland-Palatinate as Vorarlberg Sees Falling Mortality

Preclinical Study Flags NPM1 as Potential Target in Some Bowel and Liver Cancers

Zymeworks and BeOne Say Phase 3 Zanidatamab Regimens Top Two Years’ Survival in First-Line HER2+ GEA

Never miss stories about

Oncology